Federal regulators in the United States are pushing harder than ever to reduce and eventually replace animal testing in drug ...

In April 2025, the FDA announced plans to shift biomedical research for monoclonal antibodies and other medications away from animal testing toward new approaches. One year later, much speculation ...

In a roadmap to change animal testing requirements for INDs, the U.S. FDA said its new approach will improve drug safety, hasten the evaluation process, and lower costs for companies and patients.

This story is republished from STAT, the health and medicine news site that’s a partner to the Globe. Sign up for STAT’s free Morning Rounds newsletter here In an unexpected move, the US Food and Drug ...

In a bid to prioritise more human-relevant models, the US Food and Drug Administration (FDA) has enforced a plan to phase out animal testing for monoclonal antibodies (mAbs) in the preclinical stage, ...

When we imagine the process of developing new drugs, we often picture scientists working with cutting-edge technology in gleaming laboratories. But there’s a side of pharmaceutical research that is ...

The U.S. Food and Drug Administration announced Thursday that it will be phasing out a requirement that monoclonal antibodies and other drugs be tested on animals, saying in a news release that there ...

Futuristic Technology in medical concept to finding corona virus covid 19 by using ai artificial intelligence, machine learning, digital twin, 5g, big data, iot ...

Please provide your email address to receive an email when new articles are posted on . The U.S. has not seen the approval of a new sunscreen ingredient since the 1990s. The FDA’s plan to phase out ...